期刊文献+

精细化饮食管理及体质量控制联合药物治疗肥胖型PCOS的疗效分析 被引量:1

The Efficacy of Fine Diet Management andWeight Control in Combination with Drugs in the Treatment of Obese Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的观察精细化饮食管理及体质量控制联合达英-35及二甲双胍治疗肥胖型多囊卵巢综合征(PCOS)的疗效。方法将肥胖型PCOS患者120例,随机分为A组(精细化饮食管理及体质量控制联合达英-35及二甲双胍治疗组);B组(单纯口服达英-35和二甲双胍治疗组)。观察6月,2组不同治疗方法后相关指标的变化及恢复排卵和妊娠的情况。结果2种治疗方法均可使肥胖型PCOS患者的BMI、LH、T、空腹血糖、血清空腹胰岛素、卵巢体积有所下降,与治疗前相比,P<0.05;对比治疗后2组患者,A组中患者BMI、LH、T、空腹血糖、血清空腹胰岛素、卵巢体积均显著降低,与B组相比,P<0.05;A组中患者恢复排卵率、成功妊娠率均显著高于B组,P<0.05;A组60例患者中44例完成治疗,B组60例患者52例完成治疗,A组患者脱落率较高,但治疗后各项指标下降更明显,优于B组(P<0.05),排卵率及妊娠率显著高于B组(P<0.05)。结论精细化饮食管理及体质量控制联合达英-35二甲双胍治疗肥胖型多囊卵巢综合征患者,可有效提高排卵率及妊娠率,疗效显著,值得临床推广。 Objective To observe the efficacy of fine diet management and weight control in combination with Dain-35 and metformin in the treatment of obese polycystic ovary syndrome(PCOS).Methods 120 obese PCOS patients were randomly divided into Group A(fine diet management and weight control combined with Dain-35 and metformin treatment group)and Group B(Dain-35 and metformin treatment group).Observe the changes in the relevant indicators and the recovery of ovulation and pregnancy with two different treatments after 6 months.Results Both treatments resulted in a decrease in BMI,LH,T,fasting blood sugar,serum fasting insulin,and ovary volume in obese PCOS patients,which were statistically significant compared to pre-treatment(P<0.05);The ovaries were significantly reduced in volume,and the difference was statistically significant compared to Group B(P<0.05),and the recovery rate of ovulation and successful pregnancy were significantly higher than that of Group B.The difference was statistically significant(P<0.05),44 of the 60 patients in Group A completed treatment,52 patients in Group B completed treatment,and the fall rate of patients in Group A was higher,but the decrease of the indicators after treatment was more obvious,better than that of Group B(P<0.05),and the rate of ovulation and pregnancy was significantly higher than that of Group B(P<0.05).Conclusion Fine diet management and weight control combined with Dain-35 metformin to treat obese patients with polycystic ovary syndrome can effectively reduce and improve ovulation rate and pregnancy rate,the effect is significant,worthy of clinical promotion.
作者 马骐 穆雅琴 梅晓霞 朱壮彦 王晓禾 戚瑞珍 钱正宇 MA Qi;MU Ya-qin;MEI Xiao-xia;ZHU Zhuang-yan;WANG Xiao-he;QI Rui-zhen;QIAN Zheng-yu(Department of Reproductive Medicine,The Third People's Hospital of Datong,Datong Shanxi,037009;Medical School,Shanxi Datong University,Datong Shanxi,037009)
出处 《山西大同大学学报(自然科学版)》 2021年第1期91-95,共5页 Journal of Shanxi Datong University(Natural Science Edition)
基金 山西省社会发展基金项目[201903D321021] 大同市社会发展重点研发项目[2017094]
关键词 精细化饮食管理 体质量控制 肥胖型多囊卵巢综合征 达英-35 二甲双胍 fine diet management weight control obese polycystic ovary syndrome Dain-35 metformin
  • 相关文献

参考文献7

二级参考文献42

  • 1赵淑萍,邵东红,戴淑真,戴红英,吴红婧.多囊卵巢综合征伴不孕患者促排卵治疗前后子宫及卵巢动脉血流动力学的研究[J].中华超声影像学杂志,2004,13(7):532-535. 被引量:26
  • 2丘彦,刘敬,周永芳,桂文武,刘淑文,王富兰,张洪英,马智.超声检测卵巢髓质面积与总面积的比值在多囊卵巢综合征诊断中的应用[J].中华妇产科杂志,2004,39(9):595-597. 被引量:14
  • 3曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2005:2814.
  • 4Dunaif A. Hyperandrogenic anovulation ( PCOS ) : a unique disorder of insulin action associated with an increased risk of noninsulin-dependent diabetes mellitus. Am J Med, 1995,98 : 33S- 39S.
  • 5Diamanti-Kandarakis E, Kouli C, Tsianateli T, et al. Therapeutic effects of mefformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol, 1998, 138: 269- 274.
  • 6Teede HI, Meyer C, Norman RJ. lnsulin-sensitisers in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother, 2005,6:2419-2427.
  • 7Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1998,83: 2694-2698.
  • 8Ducluzean PH, Cousin P, Malvoisin E, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab,2003, 88:3626-3631.
  • 9Stout DL, Fugate SE. Thiazolidinediones for treatment of polycystic ovary syndrome. Pharmacotherapy, 2005,25 : 244-252.
  • 10Legro RS.Polycystic ovary syndrome:phenotype to genotype[J].Endocrinol Metab Clin North Am,1999,28 (2):379 -396.

共引文献1516

同被引文献17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部